Related Experiment Video
Updated: Aug 20, 2025

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time
Published on: March 11, 2021
Structural basis for NaV1.7 inhibition by pore blockers
Jiangtao Zhang1,2, Yiqiang Shi3, Zhuo Huang3
1Laboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China.
Structural insights into voltage-gated sodium channel NaV1.7 reveal how pore blockers like XEN907 and TC-N1752 inhibit ion flow. This provides a framework for developing novel pain-relief medications.
Area of Science:
- Structural biology
- Neuroscience
- Pharmacology
Background:
- Voltage-gated sodium channel NaV1.7 is crucial for pain and odor perception.
- NaV1.7 dysfunction is linked to pain disorders, making it a key target for analgesics.
Purpose of the Study:
- To elucidate the structural mechanisms of NaV1.7 inhibition by specific pore blockers.
- To provide a structural basis for developing subtype-selective NaV1.7 analgesics.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was used to determine the structures of human NaV1.7/β1/β2 complexed with inhibitors.
- Electrophysiological studies were performed to assess the functional effects of the inhibitors.
Main Results:
- Cryo-EM structures revealed distinct binding sites for XEN907, TC-N1752, and NaV1.7-IN2 within the central cavity of NaV1.7.
- XEN907 and TC-N1752 induce conformational changes in key S6 helices, affecting channel gating and inactivation.
- NaV1.7-IN2 acts as a pore blocker without inducing significant conformational changes.
- Electrophysiology confirmed that XEN907 and TC-N1752 stabilize the inactivated state and prolong recovery from inactivation.
Conclusions:
- The study provides detailed structural insights into how NaV1.7 pore blockers function.
- These findings offer a structural framework for the rational design of novel, subtype-selective NaV1.7 inhibitors for pain management.
Related Concept Videos
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...

